Trials / Completed
CompletedNCT02181452
Liver Fibrosis Assessment With ShearWave Elastography
Evaluation of SWE Performances for the Non-Invasive Diagnosis of Liver Fibrosis in Patients With Chronic Liver Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,333 (actual)
- Sponsor
- SuperSonic Imagine · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chronic liver disease/fibrosis can be the result of various causes, and the result is that the liver tissue becomes stiff. ShearWave™ elastography, available on the Aixplorer® ultrasound system, is a method that can be used to measure the stiffness of organs in the body, for example the liver. This study will evaluate how this technology performs as a non-invasive test to stage liver fibrosis in patients with chronic liver disease.
Detailed description
The measurements of liver stiffness made by the Aixplorer® will be compared to (where available) : * blood markers * biopsy results * other stiffness measurement exams (FibroScan, ARFI, ElastPQ...) The influence of other (confounding) factors on the reliability of SWE measurements will be analyzed.
Conditions
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-07-04
- Last updated
- 2015-05-12
Locations
13 sites across 9 countries: Belgium, China, Denmark, France, Germany, Greece, Hong Kong, Italy, Romania
Source: ClinicalTrials.gov record NCT02181452. Inclusion in this directory is not an endorsement.